ARCHIVES

Group trials need prioritization, review, NCI official says.

This article is from The Cancer Letter archive.

Vol. 29 No. 30 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

Court Order May Clear Way From Big Landow-Blair-Switch

July 6, 1984

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

Genetic Test Identifies Patients With High Risk of Mortality

November 30, 2012

Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language

September 18, 2009